{"DataElement":{"publicId":"2946190","version":"1","preferredName":"Midostaurin Placebo Agent Not Administered Reason","preferredDefinition":"the reason related to a synthetic, indolocarbazole protein kinase C (PKC) inhibitor with anti-angiogenic properties or placebo not being administered.","longName":"2723087v1.0:2677479v1.0","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2723087","version":"1","preferredName":"Placebo Celecoxib Agent Not Administered","preferredDefinition":"information relating to celecoxib (a nonsteroidal anti-inflammatory drug (NSAID) with a diaryl-substituted pyrazole structure) or placebo not being administered.","longName":"PLAC_CEL_AGT_NOT_ADM","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2970204","version":"1","preferredName":"Placebo Celecoxib Agent","preferredDefinition":"An inactive substance, treatment or procedure that is intended to mimic as closely as possible a therapy in a clinical trial.:A nonsteroidal anti-inflammatory drug (NSAID) with a diaryl-substituted pyrazole structure. Celecoxib selectively inhibits cyclo-oxygenase-2 activity (COX-2); COX-2 inhibition may result in apoptosis and a reduction in tumor angiogenesis and metastasis.:An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect. (NCI)","longName":"C753:C1728:C1708","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Placebo","conceptCode":"C753","definition":"An inactive substance, treatment or procedure that is intended to provide baseline measurements for the experimental protocol of a clinical trial.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Celecoxib","conceptCode":"C1728","definition":"A nonsteroidal anti-inflammatory drug (NSAID) with a diaryl-substituted pyrazole structure. Celecoxib selectively inhibits cyclo-oxygenase-2 activity (COX-2); COX-2 inhibition may result in apoptosis and a reduction in tumor angiogenesis and metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7ADF17A7-69A3-111A-E040-BB89AD433ACF","latestVersionIndicator":"Yes","beginDate":"2009-12-16","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-12-16","modifiedBy":"ONEDATA","dateModified":"2009-12-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207837","version":"1","preferredName":"Not Administered","preferredDefinition":"Not; used for negation of a word or group of words.:Given.","longName":"C25594:C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-3219-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CALGB CRF:Cancer and Leukemia Group B Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"443DF3B3-CC78-58AB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-21","endDate":null,"createdBy":"ALAIS","dateCreated":"2008-01-21","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2677479","version":"1","preferredName":"Agent Not Administered Reason","preferredDefinition":"the reason an agent was not administered.","longName":"AGT_N_ADM_RSN","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"75","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2567790","version":"1","preferredName":"Other","longName":"2567790","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D5DB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"KUMMEROA","dateModified":"2023-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"396938BF-D665-6F82-E044-0003BA3F9857","beginDate":"2007-09-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-05","modifiedBy":"CAMPBELB","dateModified":"2007-09-05","deletedIndicator":"No"},{"value":"Grade 2, 3, or 4 allergic reaction/hypersensitivity (including drug fever)","valueDescription":"Grade 2, 3, or 4 allergic reaction/hypersensitivity (including drug fever)","ValueMeaning":{"publicId":"2677481","version":"1","preferredName":"Grade 2, 3, or 4 allergic reaction/hypersensitivity (including drug fever)","longName":"2677481","preferredDefinition":"Grade 2, 3, or 4 allergic reaction/hypersensitivity (including drug fever)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3969216B-89B0-3B68-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"396948E7-F982-0861-E044-0003BA3F9857","beginDate":"2007-09-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-05","modifiedBy":"ONEDATA","dateModified":"2007-09-05","deletedIndicator":"No"},{"value":"Grade 3 or 4 cardiac ischemia/infarction","valueDescription":"Grade 3 or 4 cardiac ischemia/infarction","ValueMeaning":{"publicId":"2677482","version":"1","preferredName":"Grade 3 or 4 cardiac ischemia/infarction","longName":"2677482","preferredDefinition":"Grade 3 or 4 cardiac ischemia/infarction","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"39694446-AAF2-58A0-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"396948E7-F994-0861-E044-0003BA3F9857","beginDate":"2007-09-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-05","modifiedBy":"ONEDATA","dateModified":"2007-09-05","deletedIndicator":"No"},{"value":"Grade 2, 3, or 4 cytokine release syndrome/acute infusion reaction","valueDescription":"Grade 2, 3, or 4 cytokine release syndrome/acute infusion reaction","ValueMeaning":{"publicId":"2677483","version":"1","preferredName":"Grade 2, 3, or 4 cytokine release syndrome/acute infusion reaction","longName":"2677483","preferredDefinition":"Grade 2, 3, or 4 cytokine release syndrome/acute infusion reaction","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"39694600-038B-0513-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"396948E7-F9A6-0861-E044-0003BA3F9857","beginDate":"2007-09-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-05","modifiedBy":"ONEDATA","dateModified":"2007-09-05","deletedIndicator":"No"},{"value":"Grade 3 or 4 left ventricular systolic dysfunction","valueDescription":"Grade 3 or 4 left ventricular systolic dysfunction","ValueMeaning":{"publicId":"2677484","version":"1","preferredName":"Grade 3 or 4 left ventricular systolic dysfunction","longName":"2677484","preferredDefinition":"Grade 3 or 4 left ventricular systolic dysfunction","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"39690BB2-E66C-162D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"396948E7-F9B8-0861-E044-0003BA3F9857","beginDate":"2007-09-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-05","modifiedBy":"ONEDATA","dateModified":"2007-09-05","deletedIndicator":"No"},{"value":"Grade 3 or 4 other clinically significant AEs","valueDescription":"Grade 3 or 4 other clinically significant AEs","ValueMeaning":{"publicId":"2677485","version":"1","preferredName":"Grade 3 or 4 other clinically significant AEs","longName":"2677485","preferredDefinition":"Grade 3 or 4 other clinically significant AEs","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3967BB88-7501-3A7C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"396948E7-F9CA-0861-E044-0003BA3F9857","beginDate":"2007-09-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-05","modifiedBy":"ONEDATA","dateModified":"2007-09-05","deletedIndicator":"No"},{"value":"Pulmonary Toxicity","valueDescription":"Pulmonary Toxicity","ValueMeaning":{"publicId":"2871574","version":"1","preferredName":"Pulmonary Toxicity","longName":"2871574","preferredDefinition":"Relating to the lungs.: Toxicity; the degree to which something is poisonous.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pulmonary","conceptCode":"C13304","definition":"Relating to the lungs as the intended site of administration, where the pharmaceutical product is administered, usually by inhalation, for local action in the lower respiratory tract or for systemic action after absorption via the lower respiratory tract.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Toxicity","conceptCode":"C27990","definition":"The finding of bodily harm due to the poisonous effects of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"69442CAD-A1E6-A995-E040-BB89AD4320DF","latestVersionIndicator":"Yes","beginDate":"2009-05-06","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-05-06","modifiedBy":"ONEDATA","dateModified":"2009-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"746C8379-A625-BB84-E040-BB89AD437E25","beginDate":"2009-09-25","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-09-25","modifiedBy":"ONEDATA","dateModified":"2009-09-25","deletedIndicator":"No"},{"value":"Other non-heme toxicity","valueDescription":"Other non-heme toxicity","ValueMeaning":{"publicId":"2947245","version":"1","preferredName":"Other non-heme toxicity","longName":"2947245","preferredDefinition":"Other non-heme toxicity","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74B9639F-F184-0172-E040-BB89AD436135","latestVersionIndicator":"Yes","beginDate":"2009-09-29","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-09-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"74B9639F-F19D-0172-E040-BB89AD436135","beginDate":"2009-09-29","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-09-29","modifiedBy":"ONEDATA","dateModified":"2009-09-29","deletedIndicator":"No"},{"value":"Heme toxicity","valueDescription":"Heme toxicity","ValueMeaning":{"publicId":"2947238","version":"1","preferredName":"Heme toxicity","longName":"2947238","preferredDefinition":"Heme toxicity","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74B9E8DE-DBA0-BE28-E040-BB89AD4363B5","latestVersionIndicator":"Yes","beginDate":"2009-09-29","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-09-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"74B9E8DE-DBB9-BE28-E040-BB89AD4363B5","beginDate":"2009-09-29","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-09-29","modifiedBy":"ONEDATA","dateModified":"2009-09-29","deletedIndicator":"No"},{"value":"Cardiac toxicity","valueDescription":"Cardiac Toxicity","ValueMeaning":{"publicId":"2684343","version":"1","preferredName":"Cardiac Toxicity","longName":"2684343","preferredDefinition":"Cardiac Toxicity","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3AE5174E-8DAE-37C3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"74B9E8DE-DBCD-BE28-E040-BB89AD4363B5","beginDate":"2009-09-29","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-09-29","modifiedBy":"ONEDATA","dateModified":"2009-09-29","deletedIndicator":"No"},{"value":"No missed doses","valueDescription":"No missed doses","ValueMeaning":{"publicId":"2946192","version":"1","preferredName":"No missed doses","longName":"2946192","preferredDefinition":"No missed doses","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746C7E63-C742-9922-E040-BB89AD437B52","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"746C7F31-9B80-D59D-E040-BB89AD437B66","beginDate":"2009-09-25","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-09-25","modifiedBy":"ONEDATA","dateModified":"2009-09-25","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008554","version":"1","preferredName":"Treatment/Off-treatment Reasons","preferredDefinition":"justification for or explanation of the administration or cessation of therapy.","longName":"TX_OTX_RSNS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2C9BE32-8BDB-649C-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2240632","version":"1","preferredName":"Reason","preferredDefinition":"An explanation of the cause of some phenomenon or action.","longName":"C25638","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F9FA7953-8391-043D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-30","endDate":null,"createdBy":"PWEST","dateCreated":"2005-06-30","modifiedBy":"ONEDATA","dateModified":"2005-06-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"396938B8-0BD3-5EBC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-05","modifiedBy":"ALAIS","dateModified":"2009-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811909","version":"1","longName":"Leukemia","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"10000362","version":"1","longName":"AML Prev Untreated","context":"CTEP"}]},{"publicId":"2008608","version":"1","longName":"Phase","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811890","version":"1","longName":"Phase III","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Reason for missed/reduced Mid","type":"Preferred Question Text","description":"Reason for missed/reduced Midostaurin/Placebo dose","url":null,"context":"CTEP"}],"origin":"CALGB CRF:Cancer and Leukemia Group B Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"746C58E3-54C3-61A0-E040-BB89AD4332AE","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-09-25","modifiedBy":"ALAIS","dateModified":"2009-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}